Matches in Wikidata for { <http://www.wikidata.org/entity/Q85488040> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q85488040 description "artículu científicu espublizáu en xunetu de 2015" @default.
- Q85488040 description "scientific article published on 21 July 2015" @default.
- Q85488040 description "wetenschappelijk artikel" @default.
- Q85488040 description "наукова стаття, опублікована в липні 2015" @default.
- Q85488040 name "Re: Cost-effectiveness of continuous subcutaneous apomorphine in the treatment of Parkinson's Disease in the UK and Germany" @default.
- Q85488040 name "Re: Cost-effectiveness of continuous subcutaneous apomorphine in the treatment of Parkinson's Disease in the UK and Germany" @default.
- Q85488040 type Item @default.
- Q85488040 label "Re: Cost-effectiveness of continuous subcutaneous apomorphine in the treatment of Parkinson's Disease in the UK and Germany" @default.
- Q85488040 label "Re: Cost-effectiveness of continuous subcutaneous apomorphine in the treatment of Parkinson's Disease in the UK and Germany" @default.
- Q85488040 prefLabel "Re: Cost-effectiveness of continuous subcutaneous apomorphine in the treatment of Parkinson's Disease in the UK and Germany" @default.
- Q85488040 prefLabel "Re: Cost-effectiveness of continuous subcutaneous apomorphine in the treatment of Parkinson's Disease in the UK and Germany" @default.
- Q85488040 P1433 Q85488040-5A82D5B9-5152-4B15-AE74-7D3BC06D7C32 @default.
- Q85488040 P1476 Q85488040-B49E601D-C374-4B19-B74E-451E46F43E7C @default.
- Q85488040 P2093 Q85488040-9F52E968-1257-447B-A20E-258F6AA6AE0B @default.
- Q85488040 P2093 Q85488040-AD478ADB-0FCF-45BA-911D-DB8E91D13058 @default.
- Q85488040 P304 Q85488040-23AC07D1-D6FF-4D1F-8711-04A6898E2EB7 @default.
- Q85488040 P31 Q85488040-390DAD7F-3F09-4F5B-AA0B-9427BBCE2749 @default.
- Q85488040 P356 Q85488040-62F7C9F3-0DEA-45F6-995D-95074815AD4F @default.
- Q85488040 P433 Q85488040-63AF41CF-CD8E-45FF-B4C8-7B1925EDC831 @default.
- Q85488040 P478 Q85488040-0E8F7AA9-B4F2-4608-946A-E36812CC3C4A @default.
- Q85488040 P577 Q85488040-3CA32708-F892-4C71-A0D4-7B3CB21DD81B @default.
- Q85488040 P698 Q85488040-087B416D-B6BF-43A1-8DC4-525FDBCA613F @default.
- Q85488040 P921 Q85488040-463FA8D2-101D-4881-B1E5-0087BE0232F4 @default.
- Q85488040 P921 Q85488040-BCE3D686-B4B6-4936-A9F9-1BB162F31728 @default.
- Q85488040 P921 Q85488040-F05FAE69-7827-4F22-BFB8-EFE67695D902 @default.
- Q85488040 P356 13696998.2015.1066797 @default.
- Q85488040 P698 26121159 @default.
- Q85488040 P1433 Q6295521 @default.
- Q85488040 P1476 "Re: Cost-effectiveness of continuous subcutaneous apomorphine in the treatment of Parkinson's Disease in the UK and Germany" @default.
- Q85488040 P2093 "Adrian C Williams" @default.
- Q85488040 P2093 "Gillian Barnett" @default.
- Q85488040 P304 "858-859" @default.
- Q85488040 P31 Q13442814 @default.
- Q85488040 P356 "10.3111/13696998.2015.1066797" @default.
- Q85488040 P433 "11" @default.
- Q85488040 P478 "18" @default.
- Q85488040 P577 "2015-07-21T00:00:00Z" @default.
- Q85488040 P698 "26121159" @default.
- Q85488040 P921 Q11085 @default.
- Q85488040 P921 Q1754768 @default.
- Q85488040 P921 Q269111 @default.